COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
- PMID: 32414804
- DOI: 10.1136/annrheumdis-2020-217681
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
Keywords: antirheumatic agents; autoimmune diseases; sarcoidosis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.Ann Rheum Dis. 2021 Feb;80(2):e15. doi: 10.1136/annrheumdis-2020-217738. Epub 2020 May 15. Ann Rheum Dis. 2021. PMID: 32414805 No abstract available.
Comment on
-
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
